Communiqués

27/05 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates GL
27/05 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates AQ
09/03 AsymBio Completes its Dual-Site, One-Center Network with Fengxian Commercial Manufacturing Site Operational, Enhancing End-to-End Biologics CDMO Capabilities GL
12/11/24 Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow BU
06/11/24 Building a World-Class Synthetic Biology Lab: Asymchem’s Self-Developed STAR System Empowers Protein Design BU
31/10/24 Advanced Manufacturing, Global Reach, and Streamlined Services - Asymchem Impresses at CPHI Milan 2024 AQ
30/10/24 Advanced Manufacturing, Global Reach, and Streamlined Services — Asymchem Impresses at CPHI Milan 2024 BU
02/08/24 Asymchem Inaugurates Its First European Small Molecule Development and API Pilot Plant Manufacturing Site at Discovery Park in Sandwich, Kent, UK BU
21/05/24 Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities BU
20/10/22 AUM Biosciences and Asymchem Complete Phase II API Production Campaign of Novel TRK Inhibitor AQ
20/04/22 Asymchem Laboratories Tianjin : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section PU
06/03/22 Asymchem Laboratories Tianjin : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section PU
Aucun résultat pour cette recherche
🔇